Could hookworm saliva lead to a new treatment for type 2 diabetes? 15 September 2021 Sometimes medical breakthroughs appear in the most unexpected forms and that’s why researchers are hopeful that the humble hookworm could hold the key to a new diabetes treatment. Researchers at James Cook University and Macrobiome Therapeutics believe the anti-inflammatory properties of the creature’s saliva may help prevent or delay the development of type 2 diabetes. “If the project is successful and we come up with a drug [for diabetes] inspired by parasitic worms … that will be a game changer, ” molecular parasitologist Dr Alex Loukas said. Studies in developing countries found that people who took deworming medication to remove parasites became more susceptible to conditions like diabetes. “Parasitic worms secrete all sorts of compounds that have anti-inflammatory properties to stop your immune system from flushing [the worms] out,” he said. Hookworms are also being studied for other purposes, such as using their larvae to treat gluten intolerance and coeliac disease, and genetically modifying hookworms to protect frontline soldiers from chemical and biological threats. “There is something in these [parasitic] infections that can prevent the onset of these types of diseases and our goal now is to try to distil those in molecular medicine.” Researchers hope to conduct preclinical studies (the testing stage before human trials) within the next five years. Key Findings Researchers are working to develop a new drug for type 2 diabetes by determining what therapeutic properties hookworm saliva has. Hookworms are also being studied for other purposes, such as treating gluten intolerance and coeliac disease, and protecting soldiers from biological and chemical threats. Researchers hope to conduct preclinical studies for drugs derived from hookworms within the next five years.
News 27 May 2026 Tzield listing a game-changer for early-stage type 1 diabetes The first new therapy for type 1 diabetes in nearly a century, which works to delay the need for insulin therapy in type 1 diabetes, has been approved for use in Australia by the Therapeutic Goods Administration. Continue Reading
Blog 27 May 2026 How diabetes, depression, anxiety, and medicines are connected People with diabetes can be depressed or anxious more often than people without diabetes. Studies show that when you have diabetes, you are almost twice as likely to be depressed, regardless of the type of diabetes. Continue Reading
Media releases 9 May 2026 Research reveals genes may determine who benefits most from popular weight-loss and diabetes medicines New research supported by has confirmed that a person’s genes can influence how well widely used diabetes medicines... Continue Reading